Portfolio of Biotech Stocks: Diabetes

Here is a sample of 5 biotech stocks that provide diabetes treatments.

To inspect the performance of the Biotech Stocks: Diabetes portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 4 stocks included in the portfolio computations are: DXCM, PODD, MNKD and MDT. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. TNDM was excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $111,064. The percent return is 1,010.64%. The annualized return is 27.22%.


NOTE: The stocks included in the table and chart are representative of the industry. They are not recommendations.

Related Portfolios

Portfolio of Biotech Stocks

Portfolio of Dividend-Paying Pharmaceutical Stocks